Travere Therapeutics Net Income 2012-2021 | TVTX

Travere Therapeutics net income from 2012 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Travere Therapeutics Annual Net Income
(Millions of US $)
2020 $-169
2019 $-146
2018 $-103
2017 $-60
2016 $-48
2015 $117
2014 $-111
2013 $-35
2012 $-30
2011 $-3
Travere Therapeutics Quarterly Net Income
(Millions of US $)
2021-06-30 $-39
2021-03-31 $-54
2020-12-31 $-122
2020-09-30 $-23
2020-06-30 $-26
2020-03-31 $1
2019-12-31 $-30
2019-09-30 $-36
2019-06-30 $-39
2019-03-31 $-41
2018-12-31 $-7
2018-09-30 $-55
2018-06-30 $-22
2018-03-31 $-18
2017-12-31 $-18
2017-09-30 $-18
2017-06-30 $-13
2017-03-31 $-11
2016-12-31 $-9
2016-09-30 $-37
2016-06-30 $-13
2016-03-31 $11
2015-12-31 $-2
2015-09-30 $106
2015-06-30 $-26
2015-03-31 $40
2014-12-31 $-29
2014-09-30 $-18
2014-06-30 $12
2014-03-31 $-76
2013-12-31 $-14
2013-09-30 $-11
2013-06-30 $-5
2013-03-31 $-5
2012-12-31 $-27
2012-11-30 $-0
2012-09-30 $-8
2012-08-31 $-0
2012-06-30 $-5
2012-05-31 $-0
2012-03-31 $-4
2012-02-29
2011-12-31 $-3
2011-11-30 $-0
2011-09-30 $-0
2011-08-31 $-0
2011-06-30 $-0
2011-05-31 $-0
2011-03-31 $-0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.596B $0.198B
Travere Therapeutics Inc. is a biopharmaceutical company. It engages to identify, develop and deliver life-changing therapies. Travere Therapeutics Inc., formerly known as Retrophin Inc., is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76